Bug of the Month helps educate readers about existing and emerging pathogens of clinical importance in healthcare facilities today.
Seqirus announced today that the US Food and Drug Administration (FDA) has approved Fluad Quadrivalent, touted as the first and only adjuvanted quadrivalent influenza vaccine, developed to help protect adults 65 years and older against seasonal influenza.
Christina Tan, MD, MPH, state epidemiologist and assistant commissioner with the New Jersey Department of Health, discusses the current coronavirus outbreak and how infection prevention efforts can help curb its spread.
Sustainability of high hand hygiene rates is extremely challenging and continuously requires resources and substantial effort.
Infection control specialists need to know how to successfully design and implement an effective infection prevention program.
New technologies have emerged in EVS practices that infection preventionists can help review before a facility decides to implement.
Nurses think they should play a professional role in antimicrobial stewardship (AS) programs, but a culture of safety at hospitals that focuses on other kinds of providers often hinders nurse involvement.
“These estimates are reassuring,” says Brendan Flannery, PhD, the CDC’s investigator for the US Flu Vaccine Effectiveness Network.
Discoveries About C. diff Underscore That What Happens Outside Hospitals Doesn’t Always Stay Outside Hospitals
Hospital administrators and infection preventionists have to contend with diversity among C. diff isolates.
Health officials say that this is a particularly bad year for an extended influenza season since flu symptoms and some of the symptoms of the novel coronavirus, COVID-19, are the same (fever, cough, shortness of breath).